Alp is a startup based in Germany.
Alp develops a platform that uses human tonsil organoid technology combined with protein AI to predict, validate, and reduce immunogenicity risk in therapeutic antibodies before clinical development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.